Atria Wealth Solutions’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,823
| Closed | -$556K | – | 1960 |
|
|
2024
Q3 | $556K | Buy |
2,823
+1,115
| +65% | +$220K | 0.01% | 1186 |
|
|
2024
Q2 | $353K | Sell |
1,708
-1,150
| -40% | -$238K | ﹤0.01% | 1398 |
|
|
2024
Q1 | $774K | Buy |
2,858
+696
| +32% | +$189K | 0.01% | 1028 |
|
|
2023
Q4 | $511K | Sell |
2,162
-105
| -5% | -$24.8K | 0.01% | 1186 |
|
|
2023
Q3 | $444K | Sell |
2,267
-62
| -3% | -$12.2K | 0.01% | 1180 |
|
|
2023
Q2 | $490K | Sell |
2,329
-44
| -2% | -$9.25K | 0.01% | 1165 |
|
|
2023
Q1 | $479K | Sell |
2,373
-37
| -2% | -$7.47K | 0.01% | 1161 |
|
|
2022
Q4 | $525K | Sell |
2,410
-289
| -11% | -$63K | 0.01% | 1052 |
|
|
2022
Q3 | $531K | Buy |
2,699
+95
| +4% | +$18.7K | 0.01% | 983 |
|
|
2022
Q2 | $557K | Sell |
2,604
-13
| -0.5% | -$2.78K | 0.01% | 892 |
|
|
2022
Q1 | $743K | Buy |
+2,617
| New | +$743K | 0.01% | 857 |
|